Vervaardiging van overige farmaceutische producten

NACE 21209

Active companies, 5-year failure rate, regional split and recent bankruptcies for this NACE sector.

97 enterprises with this primary NACE (establishment units not counted)

Counted in the KBO's NACE 2025 nomenclature, the one in which code 21209 exists.

Enterprises97

Bankruptcies (5y)4

Failure rate4.12%

Regions covered4

Provinces covered11

Bankruptcies and the failure rate are attributed by each company's current primary NACE, not the NACE at the time of bankruptcy (which the gazette does not record).

Key figures for NACE division 21

fiscal year 2024 · median over 46 filed annual accounts

Median solvency

46.9%

Median equity

€108k

Median net result

€-1k

Annual accounts in sample

These medians cover the whole NACE division 21, not NACE 21209 on its own. There are too few filed annual accounts per five-digit code to compute it separately.
Source: NBB annual accounts, all schema types combined. Medians computed internally.

Regional split

by region · 94 of 97 enterprises with a registered office on file

Vlaanderen 46 · 48.9%

Wallonië 39 · 41.5%

Brussel 6 · 6.4%

Unknown 3 · 3.2%

Recent bankruptcies in this sector

Date	Company
10-10-2025	UNIVERCELLS BE 0502.742.288
15-04-2025	ROMARK BELGIUM BE 0536.645.867
24-01-2025	ORGENESIS SERVICES SRL BE 0790.353.624
31-07-2024	NOVALON BE 0877.126.557

Geographic distribution

by province · based on the establishment address

West Flanders WVL 2

East Flanders OVL 12

Antwerp ANT 18

Flemish Brabant VLB 6

Limburg LIM 8

Brussels BRU 6

Hainaut HAI 10

Walloon Brabant WBR 5

Namur NAM 2

Liège LIE 18

Luxembourg LUX 4

fewer moremax 18